En
Encoded Ther
S San Francisco CAFounded 201650 employees
Private CapbiotechPrivateGenetic Medicine
Platform: AAV Cis-reg
Market Cap
N/A
All Drugs
4
Clinical Trials
12
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ENC-6986 | ENC-6986 | Approved | 3 | PLK4 | MCC | ||
| ENC-8622 | ENC-8622 | Phase 3 | 4 | Tau | AngelmanUrothelial Ca | ||
| ENC-4310 | ENC-4310 | Phase 1/2 | 2 | TROP-2 | PompeCholangiocarcinoma | ||
| Olpafutibatinib | ENC-9567 | Phase 3 | 3 | BCMA | SCLCHNSCC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (11)